Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
Transplantation. 2019 Feb;103(2):336-343. doi: 10.1097/TP.0000000000002220.
Heart transplantation (HTx) remains the most effective long-term treatment for advanced heart failure. Primary graft dysfunction (PGD) continues to be a potentially life-threatening early complication. In 2014, a consensus statement released by International Society for Heart and Lung Transplantation (ISHLT) established diagnostic criteria for PGD. We studied the incidence of PGD across the United Kingdom.
We analyzed the medical records of all adult patients who underwent HTx between October 2012 and October 2015 in the 6 UK heart transplant centers Preoperative donor and recipient characteristics, intraoperative details, and posttransplant complications were compared between the PGD and non-PGD groups using the ISHLT definition. Multivariable analysis was performed using logistic regression.
The incidence of ISHLT PGD was 36%. Thirty-day all-cause mortality in those with and without PGD was 31 (19%) versus 13 (4.5%) (P = 0.0001). Donor, recipient, and operative factors associated with PGD were recipient diabetes mellitus (P = 0.031), recipient preoperative bilateral ventricular assist device (P < 0.001), and preoperative extracorporeal membranous oxygenation (P = 0.023), female donor to male recipient sex mismatch (P = 0.007), older donor age (P = 0.010), and intracerebral haemorrhage/thrombosis in donor (P = 0.023). Intraoperatively, implant time (P = 0.017) and bypass time (P < 0.001) were significantly longer in the PGD cohort. Perioperatively, patients with PGD received more blood products (P < 0.001). Risk factors identified by multivariable logistic regression were donor age (P = 0.014), implant time (P = 0.038), female: male mismatch (P = 0.033), recipient diabetes (P = 0.051) and preoperative ventricular assist device/extracorporeal membranous oxygenation support (P = 0.012).
This is the first national study to examine the incidence and significance of PGD after HTx using the ISHLT definition. PGD remains a frequent early complication of HTx and is associated with increased mortality.
心脏移植(HTx)仍然是治疗晚期心力衰竭的最有效长期治疗方法。原发性移植物功能障碍(PGD)仍然是一种潜在的危及生命的早期并发症。2014 年,国际心肺移植学会(ISHLT)发布了一份共识声明,为 PGD 确立了诊断标准。我们研究了英国的 PGD 发病率。
我们分析了 2012 年 10 月至 2015 年 10 月期间在英国 6 家心脏移植中心接受 HTx 的所有成年患者的病历。根据 ISHLT 定义,比较 PGD 组和非 PGD 组的术前供体和受体特征、术中细节和移植后并发症。采用 logistic 回归进行多变量分析。
ISHLT PGD 的发生率为 36%。PGD 组和非 PGD 组的 30 天全因死亡率分别为 31 例(19%)和 13 例(4.5%)(P=0.0001)。与 PGD 相关的供体、受体和手术因素包括受体糖尿病(P=0.031)、受体术前双侧心室辅助装置(P<0.001)和术前体外膜氧合(P=0.023)、女性供体与男性受体性别不匹配(P=0.007)、供体年龄较大(P=0.010)和供体颅内出血/血栓形成(P=0.023)。术中,PGD 组的植入时间(P=0.017)和体外循环时间(P<0.001)明显较长。围手术期,PGD 组患者接受了更多的血液制品(P<0.001)。多变量 logistic 回归确定的危险因素包括供体年龄(P=0.014)、植入时间(P=0.038)、女性:男性不匹配(P=0.033)、受体糖尿病(P=0.051)和术前心室辅助装置/体外膜氧合支持(P=0.012)。
这是第一项使用 ISHLT 定义检查 HTx 后 PGD 发生率和意义的全国性研究。PGD 仍然是 HTx 的常见早期并发症,与死亡率增加有关。